Loss to Follow Up (LTFU®)

LTFU® can result in study delays, increased patient recruitment costs and compromised study data. To improve efficiency, Sponsors seek the services of MediciGlobal in proactively recovering LTFU study subjects. Our success in recovering lost-to-follow-up patients ensures that nearly all patient data is accounted for.

In a risk averse global regulatory climate, regulatory agencies are requesting that all study subjects be accounted for in the application for approval process. Our team works in 3 ways:

proactive development and implementation of patient retention programmes
recovery of patients already lost-to-follow-up and
ongoing just-in-time lost-to-follow-up
This support allows study coordinators to focus their time on patients still in the study while delivering necessary data to Sponsors for drug approvals.

Patient Retention

At MediciGlobal 100% of our award-winning VIP® retention programmes are successful in keeping children, teens and adults in studies until completion. That’s because we customise each programme to the study’s design and its patient population. So patients stay engaged – and Sponsors worldwide get the statistically powered data necessary for drug approvals. Plus, we minimize lost-to-follow-up to ensure that nearly all patient data is accounted for.

Patient Recruitment

At MediciGlobal, we have one objective: to deliver patient recruitment on or ahead of time and within budget. We provide our clients with tools and data to successfully complete patient recruitment on a global scale. Our success is due to the constant innovation of our products, unrivalled dedication to our client service and the unique way in which we constantly adapt to an ever-changing marketplace